UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Vaneck Pharmaceutical ETF (PPH)

Vaneck Pharmaceutical ETF (PPH)
88.92 -0.60 (-0.67%) 01/31/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 88.29 -0.63 (-0.71%) 01/31/25
Quote Overview for Fri, Jan 31st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
88.92
Day High
89.80
Open 89.53
Previous Close 89.52 89.52
Volume 233,100 233,100
Avg Vol 280,425 280,425
Stochastic %K 82.30% 82.30%
Weighted Alpha +0.94 +0.94
5-Day Change +1.21 (+1.38%) +1.21 (+1.38%)
52-Week Range 84.48 - 99.51 84.48 - 99.51
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 550,414,800
  • Shares Outstanding, K 6,190
  • 60-Month Beta 0.72
  • Price/Earnings ttm 15.43
  • Annual Dividend & Yield 1.71 (1.92%)
  • Most Recent Dividend 0.411 on 12/27/24
  • Management Fee 0.36%
  • INDUSTRY GROUPING:

    ETFs - Healthcare

Options Overview Details

View History
  • Implied Volatility 12.67% ( -1.00%)
  • Historical Volatility 15.85%
  • IV Percentile 46%
  • IV Rank 22.98%
  • IV High 23.15% on 08/05/24
  • IV Low 9.54% on 11/13/24
  • Put/Call Vol Ratio 0.50
  • Today's Volume 6
  • Volume Avg (30-Day) 117
  • Put/Call OI Ratio 3.81
  • Today's Open Interest 3,291
  • Open Int (30-Day) 3,049

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.48 +5.26%
on 01/14/25
Period Open: 86.28
89.92 -1.11%
on 01/28/25
+2.64 (+3.06%)
since 12/31/24
3-Month
84.48 +5.26%
on 01/14/25
Period Open: 91.31
91.98 -3.33%
on 11/01/24
-2.39 (-2.62%)
since 10/31/24
52-Week
84.48 +5.26%
on 01/14/25
Period Open: 85.06
99.51 -10.64%
on 09/03/24
+3.86 (+4.54%)
since 01/30/24

Most Recent Stories

More News
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip

Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss medicine...

OZEM : 24.51 (-1.13%)
IHE : 69.44 (-1.08%)
LLY : 811.08 (-1.48%)
MEDX : 27.33 (-0.31%)
PPH : 88.92 (-0.67%)
THNR : 23.13 (-0.74%)
Winners and Losers: Post-Election Options Analysis

Investors are anticipating which sectors might be most affected by the Trump administration. Brett Friedman, Winhall Risk Analytics/OptionMetrics Contributor takes a look at options data and implied volatility...

XLE : 87.64 (-2.80%)
ITA : 156.58 (-0.41%)
PPH : 88.92 (-0.67%)
^BTCUSD : 95,516.68 (-6.48%)
Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink?

Cencora has underperformed the broader market over the past year, and Wall Street analysts appear moderately bullish about the stock’s future.

HON : 223.72 (-0.15%)
$SPX : 6,040.53 (-0.50%)
COR : 254.21 (-1.64%)
PPH : 88.92 (-0.67%)
Stocks and ETFs in Focus as Americans Head to Polls

Election Day has approached, and the polls indicate a tight race between Democratic Party candidate Kamala Harris and Republican nominee Donald Trump. Neither candidate holds a meaningful edge in enough...

KBWB : 71.10 (-0.55%)
BE : 23.58 (+0.26%)
CVX : 149.19 (-4.56%)
JPM : 267.30 (-0.35%)
MRK : 98.82 (-0.13%)
IHE : 69.44 (-1.08%)
PPH : 88.92 (-0.67%)
UNH : 542.49 (-0.56%)
PFE : 26.52 (-1.45%)
KBH : 67.10 (-2.41%)
XLE : 87.64 (-2.80%)
XHB : 108.40 (-2.28%)
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson JNJ infused positive optimism for the broader healthcare sector after posting solid third-quarter 2024 earnings on Oct. 15. The world's biggest healthcare products maker continued with...

XLV : 146.87 (-0.32%)
JNJ : 152.15 (-0.47%)
IHE : 69.44 (-1.08%)
IYH : 62.05 (-0.40%)
PPH : 88.92 (-0.67%)
FTXH : 27.74 (-0.47%)
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR

For Immediate ReleaseChicago, IL – October 17, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

NVO : 84.45 (-1.04%)
LLY : 811.08 (-1.48%)
HRTS : 30.43 (-0.49%)
PPH : 88.92 (-0.67%)
THNR : 23.13 (-0.74%)
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy. The global...

NVO : 84.45 (-1.04%)
LLY : 811.08 (-1.48%)
HRTS : 30.43 (-0.49%)
PPH : 88.92 (-0.67%)
THNR : 23.13 (-0.74%)
Is Wall Street Bullish or Bearish on Cencora Stock?

Cencora has outperformed the broader market over the past year, and Wall Street analysts remain bullish about the stock's prospects.

COR : 254.21 (-1.64%)
$SPX : 6,040.53 (-0.50%)
PPH : 88.92 (-0.67%)
What Are Wall Street Analysts' Target Price for Abbvie Stock?

Despite AbbVie stock’s robust price performance compared to the broader market over the past year, Wall Street analysts are moderately bullish about the stock’s prospects.

ABBV : 183.90 (+4.70%)
$SPX : 6,040.53 (-0.50%)
PPH : 88.92 (-0.67%)
CERE : 44.96 (+0.74%)
WFC : 78.80 (-0.03%)
Abbvie Stock: Is Wall Street Bullish or Bearish?

Although Abbvie stock has been lagging behind the broader market over the past year, Wall Street analysts are still moderately bullish about its outlook.

ABBV : 183.90 (+4.70%)
$SPX : 6,040.53 (-0.50%)
PPH : 88.92 (-0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical...

See More

Key Turning Points

3rd Resistance Point 90.39
2nd Resistance Point 90.09
1st Resistance Point 89.51
Last Price 88.92
1st Support Level 88.63
2nd Support Level 88.33
3rd Support Level 87.75

See More

52-Week High 99.51
Fibonacci 61.8% 93.77
Fibonacci 50% 91.99
Fibonacci 38.2% 90.22
Last Price 88.92
52-Week Low 84.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Exclusive Barchart Webinar: Unlock the Power of High-Accuracy Option Trading